{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:50Z","timestamp":1786975610927,"version":"build-2736575974"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1001\/jamadermatol.2020.1988","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T11:02:15Z","timestamp":1593601335000},"page":"973","source":"Crossref","is-referenced-by-count":52,"title":["Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017"],"prefix":"10.1001","volume":"156","author":[{"given":"Selin","family":"Tokez","sequence":"first","affiliation":[{"name":"Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Wakkee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Louwman","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Noels","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands"},{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Nijsten","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loes","family":"Hollestein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands"},{"name":"Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"doi200038r1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archderm.1983.01650270061020","article-title":"Centennial paper. May 1912 (J Cutan Dis Syph 1912;30:241-255). Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. by John T. Bowen, M.D., Boston.","volume":"119","author":"Bowen","year":"1983","journal-title":"Arch Dermatol"},{"issue":"10","key":"doi200038r2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archderm.1986.01660220042010","article-title":"Carcinoma arising in Bowen\u2019s disease.","volume":"122","author":"Kao","year":"1986","journal-title":"Arch Dermatol"},{"issue":"4","key":"doi200038r3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1365-2133.1999.03100.x","article-title":"Guidelines for management of Bowen\u2019s disease. British Association of Dermatologists.","volume":"141","author":"Cox","year":"1999","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi200038r4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.TP.0000108491.62935.DF","article-title":"Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate.","volume":"77","author":"Bordea","year":"2004","journal-title":"Transplantation"},{"issue":"3","key":"doi200038r5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0190-9622(92)70208-W","article-title":"Cutaneous Bowen\u2019s disease. an analysis of 1001 cases according to age, sex, and site.","volume":"27","author":"Kossard","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"doi200038r6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2007.07861.x","article-title":"Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions.","volume":"156","author":"Trakatelli","year":"2007","journal-title":"Br J Dermatol"},{"key":"doi200038r7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer.","volume":"146","author":"Diepgen","year":"2002","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi200038r8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer.","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi200038r9","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaad.2014.07.003","article-title":"Burden of disease caused by keratinocyte cancer has increased in the Netherlands since 1989.","volume":"71","author":"Hollestein","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"doi200038r10","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.ejca.2012.01.003","article-title":"Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.","volume":"48","author":"Hollestein","year":"2012","journal-title":"Eur J Cancer"},{"issue":"3","key":"doi200038r11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mjd.2003.186","article-title":"Skin cancer is among the most costly of all cancers to treat for the Medicare population.","volume":"48","author":"Housman","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200038r12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jama.1991.03470060078030","article-title":"The subsequent risk of internal cancer with Bowen\u2019s disease. a population-based study.","volume":"266","author":"Chute","year":"1991","journal-title":"JAMA"},{"issue":"4","key":"doi200038r13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0190-9622(94)70222-5","article-title":"Bowen\u2019s disease (squamous cell carcinoma in situ) in Kauai, Hawaii. a population-based incidence report.","volume":"31","author":"Reizner","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"doi200038r14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/DSS.0000000000001980","article-title":"Trends in the incidence of Bowen disease based on a single-center study in the Netherlands.","volume":"45","author":"Jansen","year":"2019","journal-title":"Dermatol Surg"},{"issue":"1","key":"doi200038r15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-0960.2004.00025.x","article-title":"Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.","volume":"45","author":"Arlette","year":"2004","journal-title":"Australas J Dermatol"},{"issue":"1","key":"doi200038r17","first-page":"19","article-title":"Pathology databanking and biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive.","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"issue":"2 Pt 1","key":"doi200038r22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis.","volume":"13","author":"Kim","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"3","key":"doi200038r23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"1","key":"doi200038r24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1536867X1501500112","article-title":"Estimating and modeling relative survival.","volume":"15","author":"Dickman","year":"2015","journal-title":"Stata J"},{"issue":"6","key":"doi200038r25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2133.1987.tb07351.x","article-title":"Thirteen-year retrospective study of Bowen\u2019s disease in Northern Ireland.","volume":"117","author":"Eedy","year":"1987","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi200038r26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2133.1994.tb03407.x","article-title":"Body site distribution of Bowen\u2019s disease.","volume":"130","author":"Cox","year":"1994","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi200038r27","first-page":"236","article-title":"Morbus Bowen. a description of the disease in 617 patients.","volume":"68","author":"Thestrup-Pedersen","year":"1988","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"doi200038r28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.1996.tb04011.x","article-title":"Bowen\u2019s disease: statistical study of a 10 year period.","volume":"23","author":"Kovacs","year":"1996","journal-title":"J Dermatol"},{"issue":"7","key":"doi200038r29","first-page":"878","article-title":"Bowen\u2019s disease: a four-year retrospective review of epidemiology and treatment at a university center.","volume":"34","author":"Hansen","year":"2008","journal-title":"Dermatol Surg"},{"issue":"7","key":"doi200038r30","first-page":"790","article-title":"Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients.","volume":"135","author":"Jaeger","year":"1999","journal-title":"Arch Dermatol"},{"issue":"4","key":"doi200038r31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamadermatol.2015.5152","article-title":"Competing risk of death in Kaplan-Meier curves when analyzing subsequent keratinocyte cancer.","volume":"152","author":"Verkouteren","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi200038r32","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/jid.2013.35","article-title":"Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.","volume":"133","author":"Xiong","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"6","key":"doi200038r33","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2133.2012.11123.x","article-title":"Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.","volume":"167","author":"van der Leest","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi200038r34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1097-0215(19991029)83:3<314::AID-IJC5>3.0.CO;2-9","article-title":"Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ.","volume":"83","author":"Wassberg","year":"1999","journal-title":"Int J Cancer"},{"issue":"10","key":"doi200038r35","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.jid.2016.06.014","article-title":"Epidemiology of lentigo maligna and lentigo maligna melanoma in the Netherlands, 1989-2013.","volume":"136","author":"Greveling","year":"2016","journal-title":"J Invest Dermatol"},{"key":"doi200038r36","article-title":"Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk-prediction model.","author":"Tokez","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi200038r37","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/ije\/23.6.1111","article-title":"The capture-recapture method for estimation of cancer registry completeness: a useful tool?","volume":"23","author":"Schouten","year":"1994","journal-title":"Int J Epidemiol"},{"key":"doi200038r39","first-page":"A9433","article-title":"What are the health benefits of the most expensive healthcare system in Europe?","volume":"159","author":"Mackenbach","year":"2015","journal-title":"Ned Tijdschr Geneeskd"},{"key":"doi200038r40","article-title":"Increasing costs of skin cancer due to increasing incidence and introduction of pharmaceuticals, 2007-2017.","author":"Noels","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"doi200038r41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bjd.12766","article-title":"British Association of Dermatologists\u2019 guidelines for the management of squamous cell carcinoma in situ (Bowen\u2019s disease) 2014.","volume":"170","author":"Morton","year":"2014","journal-title":"Br J Dermatol"},{"key":"doi200038r42","first-page":"D1897","article-title":"The Dutch College of General Practitioners practice guideline \u2018suspicious skin lesions\u2019.","volume":"161","author":"Damen-van Beek","year":"2017","journal-title":"Ned Tijdschr Geneeskd"},{"key":"doi200038r19","volume-title":"International Classification of Diseases for Oncology","author":"Fritz","year":"2002","edition":"3rd ed"},{"key":"doi200038r20","volume-title":"Revision of the European Standard Population: Report of Eurostat\u2019s Task Force","author":"Eurostat European Commission","year":"2013","edition":"2013 ed."},{"key":"doi200038r16","unstructured":"Over werkgroepen. Integraal Kankercentrum Nederland. https:\/\/www.werkgroepeniknl.nl\/."},{"key":"doi200038r18","unstructured":"Central Bureau of Statistics website. Accessed April 15, 2019. https:\/\/www.cbs.nl\/."},{"key":"doi200038r21","unstructured":"Joinpoint trend analysis software. Version 4.7.0.0. National Cancer Institute Division of Cancer Control and Population Sciences; 2019. https:\/\/surveillance.cancer.gov\/joinpoint."},{"key":"doi200038r38","unstructured":"Share of independent treatment centers continues to increase. Vektis website. Accessed December 12, 2019. https:\/\/www.vektis.nl\/nieuws\/aandeel-zelfstandige-behandelcentra-blijft-toenemen."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2767662\/jamadermatology_tokez_2020_oi_200038_1599598432.12367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T11:04:54Z","timestamp":1599649494000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2767662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.1988","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738243725.793579643","asserted-by":"object"}]},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}